Journal
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Volume 78, Issue 4, Pages 543-545Publisher
AMER SOC TROP MED & HYGIENE
DOI: 10.4269/ajtmh.2008.78.543
Keywords
-
Funding
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Dihydroartemisinin-piperaquine (DHA-PPQ) is a promising new artemisinin combination treatment. There are no published data on the intentional use of the drug in pregnancy. Between June 2006 and January 2007, 50 Karen pregnant women with recurrent P. falciparum infections, despite 7-day treatments with quinine or artesunate (+/- clindamycin) or both, were treated with DHA-PPQ. This rescue treatment was effective and well tolerated and there was no evidence of toxicity for the mothers or the fetus. The PCR adjusted cure rate by Kaplan Meier analysis at day 63 was 92.2% (95% CI: 76.9-97.4).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available